(Q43407887)

23 November 2017

Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. (English)

1 reference

23 November 2017

phase II clinical trial

0 references

0 references

1 reference

S K Kumanyika

1

1 reference

23 November 2017

N R Cook

2

1 reference

23 November 2017

J A Cutler

3

1 reference

23 November 2017

L Belden

4

1 reference

23 November 2017

A Brewer

5

1 reference

23 November 2017

J D Cohen

6

1 reference

23 November 2017

P R Hebert

7

1 reference

23 November 2017

V I Lasser

8

1 reference

23 November 2017

J Raines

9

1 reference

23 November 2017

J Raczynski

10

1 reference

23 November 2017

L Shepek

11

1 reference

23 November 2017

L Diller

12

1 reference

23 November 2017

P K Whelton

13

1 reference

23 November 2017

M Yamamoto

14

1 reference

23 November 2017

Trials of Hypertension Prevention Collaborative Research Group

15

1 reference

23 November 2017

1 January 2005

1 reference

Journal of Human Hypertension

23 November 2017

1 reference

23 November 2017

19

1 reference

23 November 2017

1

1 reference

23 November 2017

33-45

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001774

23 November 2017

0 references

cites work

Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Systematic review of long term effects of advice to reduce dietary salt in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Method for identifying differences between existing food intake patterns and patterns that meet nutrition recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Relative contributions of dietary sodium sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

An imputation method for non-ignorable missing data in studies of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

How Far Should Salt Intake Be Reduced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Randomized trials of sodium reduction: an overview

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Dietary sodium reduction for hypertension prevention and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Salt and blood pressure in community-based intervention trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001774

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001774

1 reference

Dimensions Publication ID

23 November 2017

0 references

1 reference